Monopar Therapeutics MNPR
NASDAQ MNPR
$77.28 -0.69 (-0.88%)
As of: Oct 2, 2026 · 2:58 PM EDT

Monopar Therapeutics (MNPR) Short-term Investments (2021 - 2023)

Updated

Monopar Therapeutics' Short-term Investments came in at $4.7 million for Q1 2023, up 17.6% from the prior quarter.

Analysis

Monopar Therapeutics (MNPR) Short-term Investments (2021 - 2023) Analysis & Trends

At the end of FY2022, Monopar Therapeutics' Short-term Investments was $4 million.

  • Going back by year, Short-term Investments was -$289,664 in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Monopar Therapeutics 680.58 Mn 398.81 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 4.70 Mn
Dec 31, 2022 4.00 Mn
Dec 31, 2021 -289,664.00
API Access

Monopar Therapeutics Short-term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-investments&ticker=MNPR&period=max&api_key=YOUR_API_KEY